Literature DB >> 27307146

Maternal Risk Factors and Perinatal Characteristics for Hirschsprung Disease.

Anna Löf Granström1, Anna Svenningsson2, Eva Hagel3, Jenny Oddsberg2, Agneta Nordenskjöld4, Tomas Wester2.   

Abstract

BACKGROUND AND OBJECTIVES: Hirschsprung disease (HSCR) is a congenital defect of the enteric nervous system characterized by a lack of ganglion cells in the distal hindgut. The aim of this study was to assess the birth prevalence, perinatal characteristics, and maternal risk factors in HSCR patients in Sweden.
METHODS: This was a nationwide, population-based, case-control study of all children born in Sweden between 1982 and 2012 and registered in the Swedish Medical Birth Register. Cases were identified in the Swedish National Patient Register and data on potential maternal risk factors and patient characteristics were collected from the Swedish National Patient Register and the Swedish Medical Birth Register. Five age- and sex-matched controls were randomly selected for each case. The association between studied risk factors and HSCR was analyzed using conditional logistic regression to calculate the odds ratio (OR) and 95% confidence interval (CI).
RESULTS: The study population comprised 600 HSCR cases and 3000 controls with a male-to-female ratio of 3.7:1. The birth prevalence of HSCR was 1.91/10 000. Maternal obesity was associated with an increased risk for the child to have HSCR (OR 1.74; CI 1.25-2.44). Children with HSCR were born at an earlier gestational age (OR 1.60; CI 1.18-2.17) than control children. Associated malformations were identified in 34.5% of the cases.
CONCLUSIONS: This study showed that the Swedish birth prevalence of HSCR was 1.91/10 000. Children with HSCR disease were born at a lower gestational age than controls. Maternal obesity may increase the risk for the child to have HSCR.
Copyright © 2016 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2016        PMID: 27307146     DOI: 10.1542/peds.2015-4608

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

1.  Increased Fibronectin Impairs the Function of Excitatory/Inhibitory Synapses in Hirschsprung Disease.

Authors:  Ni Gao; Peimin Hou; Jian Wang; Tingting Zhou; Dongming Wang; Qiangye Zhang; Weijing Mu; Xiaona Lv; Aiwu Li
Journal:  Cell Mol Neurobiol       Date:  2019-11-23       Impact factor: 5.046

2.  Genome-wide association study of Hirschsprung disease detects a novel low-frequency variant at the RET locus.

Authors:  João Fadista; Marie Lund; Line Skotte; Frank Geller; Priyanka Nandakumar; Sumantra Chatterjee; Hans Matsson; Anna Löf Granström; Tomas Wester; Perttu Salo; Valtter Virtanen; Lisbeth Carstensen; Jonas Bybjerg-Grauholm; David Michael Hougaard; Mikko Pakarinen; Markus Perola; Agneta Nordenskjöld; Aravinda Chakravarti; Mads Melbye; Bjarke Feenstra
Journal:  Eur J Hum Genet       Date:  2018-01-29       Impact factor: 4.246

3.  Sporadic Hirschsprung Disease: Mutational Spectrum and Novel Candidate Genes Revealed by Next-generation Sequencing.

Authors:  Zhen Zhang; Qi Li; Mei Diao; Na Liu; Wei Cheng; Ping Xiao; Jizhen Zou; Lin Su; Kaihui Yu; Jian Wu; Long Li; Qian Jiang
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

4.  Maternal use of selective serotonin reuptake inhibitors during pregnancy is associated with Hirschsprung's disease in newborns - a nationwide cohort study.

Authors:  Sebastian Werngreen Nielsen; Perniller Møller Ljungdalh; Jan Nielsen; Bente Mertz Nørgård; Niels Qvist
Journal:  Orphanet J Rare Dis       Date:  2017-06-20       Impact factor: 4.123

5.  Classification of short-term complications after transanal endorectal pullthrough for Hirschsprung's disease using the Clavien-Dindo-grading system.

Authors:  Nils Hoff; Tomas Wester; Anna Löf Granström
Journal:  Pediatr Surg Int       Date:  2019-08-14       Impact factor: 1.827

6.  ASSOCIATION OF RS2435357 AND RS1800858 POLYMORPHISMS IN RET PROTO-ONCOGENE WITH HIRSCHSPRUNG DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS.

Authors:  Abdolhamid Amooee; Mohamad Hosein Lookzadeh; Seyed Reza Mirjalili; Seyed Mohsen Miresmaeili; Kazem Aghili; Masoud Zare-Shehneh; Hossein Neamatzadeh
Journal:  Arq Bras Cir Dig       Date:  2019-10-21

7.  Mortality in Swedish patients with Hirschsprung disease.

Authors:  Anna Löf Granström; Tomas Wester
Journal:  Pediatr Surg Int       Date:  2017-09-07       Impact factor: 1.827

8.  Gli family zinc finger 1 is associated with endothelin receptor type B in Hirschsprung disease.

Authors:  Weizhen Liu; Juan Pan; Jinbo Gao; Xiaoming Shuai; Shaotao Tang; Guobin Wang; Kaixiong Tao; Chuanqing Wu
Journal:  Mol Med Rep       Date:  2018-02-15       Impact factor: 2.952

9.  Lipopolysaccharide upregulates miR-132/212 in Hirschsprung-associated enterocolitis, facilitating pyroptosis by activating NLRP3 inflammasome via targeting Sirtuin 1 (SIRT1).

Authors:  Hongxing Li; Lingling Zhou; Zhengke Zhi; Xiurui Lv; Zhonghong Wei; Xin Zhang; Weibing Tang; Meiling Tong
Journal:  Aging (Albany NY)       Date:  2020-09-20       Impact factor: 5.682

10.  Postoperative enterocolitis assessment using two different cut-off values in the HAEC score in Hirschsprung patients undergoing Duhamel and Soave pull-through.

Authors:  Afnandito Valeno Risky Sukarelawanto; Azmi Ritana; Naisya Balela; Wayan Julita Krisnanti Putri; Dian Nirmala Sirait; Vincentia Meta Widya Paramita; Andika Purba Sasmita; Andi Dwihantoro; Akhmad Makhmudi
Journal:  BMC Pediatr       Date:  2020-10-02       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.